| T.ROWE GLOBAL VALUE EQUITY FUND I | RVI GLOBAL VALOR | 36,02% | 78,37% | 91,42% | 212,27% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 56,25% | 50,95% | 79,02% | 212,18% |
| MFS MERIDIAN U.S. CONCENTRATED GROWTH FUND W1-USD | RVI USA CRECIMIENTO | 4,53% | 29,53% | 41,89% | 212,16% |
| AXA IM US EQUITY QI B EUR ACC | RVI USA | 20,80% | 62,97% | 74,04% | 211,79% |
| AXA IM US EQUITY QI B USD ACC | RVI USA | 20,19% | 63,30% | 74,02% | 211,75% |
| FIDELITY FUNDS-JAPAN VALUE A-ACC-JPY | RVI JAPÓN VALOR | 43,02% | 78,43% | 96,33% | 211,64% |
| JPM GLOBAL NATURAL RESOURCES D (ACC) USD | RVI MATERIAS PRIMAS | 58,31% | 65,62% | 98,71% | 211,50% |
| CAPITALATWORK FOYER UMBRELLA - CONTRARIAN EQUITIES AT WORK I | RVI GLOBAL | 22,21% | 49,81% | 59,51% | 211,39% |
| GOLDMAN SACHS US EQUITY ESG PORTFOLIO I GBP DIS | RVI USA | 12,45% | 47,67% | 62,46% | 211,38% |
| ROBECO EMERGING MARKETS EQUITIES I USD | RVI EMERGENTES | 54,21% | 89,86% | 68,10% | 211,34% |
